OpenFilings

ORAMED PHARMACEUTICALS INC.

Form10-Q

Report Period2026-09-30

Date Filed2026-11-12

Time Filed17:23:21

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

QUARTERLY REPORT
FORM OF AMENDED AND RESTATED A&R SENIOR SECURED CONVERTIBLE NOTE
FORM OF AMENDED AND RESTATED ORDINARY SHARE PURCHASE WARRANT
FORM OF AMENDED AND RESTATED PRE-FUNDED ORDINARY SHARE WARRANT
AMENDMENT TO PROFIT SHARING LOAN AGREEMENT WITH RABI BINYAMIN 4 TAMA 38 LTD., DA
FIRST AMENDMENT TO CONSULTING AGREEMENT, DATED AS OF SEPTEMBER 24, 2026 AND EFFE
SECOND AMENDMENT TO EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 24, 2026, BY AND
SECOND AMENDMENT TO EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 24, 2026 AND EFF
SECOND AMENDMENT TO CONSULTING AGREEMENT, DATED AS OF SEPTEMBER 24, 2026 AND EFF
FIFTH AMENDMENT TO CONSULTING AGREEMENT, DATED AS OF SEPTEMBER 24, 2026 AND EFFE
SEVENTH AMENDMENT TO EMPLOYMENT AGREEMENT, DATED AS OF AUGUST 31, 2026 AND EFFEC
EIGHTH AMENDMENT TO EMPLOYMENT AGREEMENT, DATED AS OF SEPTEMBER 24, 2026 AND EFF
OPTION CANCELLATION AND RELEASE AGREEMENT BETWEEN ORAMED PHARMACEUTICALS INC. AN
OPTION CANCELLATION AND RELEASE AGREEMENT BETWEEN ORAMED PHARMACEUTICALS INC. AN
OPTION CANCELLATION AND RELEASE AGREEMENT BETWEEN ORAMED PHARMACEUTICALS INC. AN
GUARANTY AND INDEMNITY AGREEMENT BY AND AMONG MAR DEVELOPMENT LLC, AMIR RICHULSK
CERTIFICATION
CERTIFICATION
CERTIFICATION
CERTIFICATION
Filing on SEC Edgar